Table 2 Covariates and outcome measures to be collected
Category of covariate | Data to be collected |
|---|---|
Patient covariates | Age |
Height | |
Sex | |
Weight | |
Preoperative Charlson Comorbidity Index | |
ASA grade | |
Polypharmacy (> 4 medications) | |
CFS | |
EFS | |
Cognitive impairment using Montreal Cognitive Assessment (MoCA) | |
Cancer covariates | TNM stage |
Tumour location | |
Preoperative chemo/radiotherapy | |
Operative covariates | Procedure or not |
Procedure type | |
Duration of surgery | |
Postoperative covariates | Postoperative chemo/radiotherapy |
Major postoperative complications | |
Primary Outcome measures | EORTC QLQ C30 at 6 and 12 weeks |
WHO-DAS 12 item at 6 and 12 weeks | |
CFS and EFS at 12 weeks | |
Secondary outcome measures | Clavien Dindo (Postoperative morbidity) – collected on days 1,3,5 and 8 post-surgery |
90-day Mortality | |
Days alive and at home 30-days (DAH30) |